CPH
Click for more information
0.00% 0.9¢ creso pharma limited

Ann: Mernova on track for quarter-on-quarter revenue growth, page-18

  1. Shane456
    267 Posts.
    lightbulb Created with Sketch. 52
    clock Created with Sketch.
    07/12/21
    20:24
    Post #: 58140536
    hope your savaging old mates over at can who have 4.33 rev 25mil costs or ac8 who made just 230k but are down 8.6 mill !!!!,,,Makes no sense how these companies can continue or even exist .. people involved must thank god every day that the asx exists
    Last edited by Shane456: 07/12/21
    CPH Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 2  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TBN Tamboran is developing the NT Beetaloo Basin. To get there, it's listing at $36/sh on the NYSE
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
SXL Southern Cross says no to buy up of Australian Community Media assets
right-arrow Created with Sketch.
SFX Sheffield Resources achieves milestone production, shipments at Thunderbird, WA
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.